We have five factories and 23 years of experience in plant extracts

Technical Articles

We hold regular seminars and welcome inquiries if you have any questions

Let's talk

Diosmin: Complete Guide to Venous Health, Circulatory Support & Hesperidin Synergy (2026)

2026-11-23
Related Product
Hesperidin
The Hesperidin produced by Green Sky Bio is of high quality, focusing on plant extracts for 21 years
Hesperidin

Table of Contents

  • What Is Diosmin and Why Is It the Gold Standard for Venous Health?

  • Natural Sources: Citrus Bioflavonoids and the Diosmin-Hesperidin Relationship

  • Clinical Evidence for Chronic Venous Insufficiency and Varicose Veins

  • Hemorrhoid Treatment: Acute Episodes and Maintenance Therapy

  • Mechanisms of Action: Venotonic, Vasoprotective, and Anti-Inflammatory

  • Lymphatic Health and Edema Management

  • Quality Standards, Particle Size, and Micronized Diosmin

  • How to Source Premium Diosmin: A Buyer's Guide

  • Applications in Supplements, Pharmaceuticals, and Topical Formulations

  • Safety, Dosage, and Regulatory Compliance

  • Why Choose Greensky Bio as Your Diosmin Supplier


1. What Is Diosmin and Why Is It the Gold Standard for Venous Health?

Diosmin (7-rutinosyl-diosmetin) is a naturally occurring flavonoid glycoside derived primarily from citrus fruits (oranges, lemons, grapefruits). It is the predominant bioactive compound in the citrus bioflavonoid complex and is widely recognized as the most effective natural ingredient for supporting venous health, capillary integrity, and circulatory function.

Diosmin has been used clinically for over 50 years, particularly in Europe, where micronized purified flavonoid fraction (MPFF) — a combination of 90% diosmin and 10% Hesperidin — is a prescription medication for chronic venous insufficiency and hemorrhoidal disease. The landmark Daflon 500 formulation has been the subject of over 60 clinical trials, establishing diosmin as one of the most extensively researched venoactive compounds in modern medicine.

The global diosmin market is projected to reach USD 250 million by 2028, driven by the increasing prevalence of chronic venous disorders (affecting up to 40% of adults in developed countries), growing awareness of natural circulatory health solutions, and expanding applications in cosmetic formulations targeting vascular health.

Hangzhou Greensky Biological Tech Co., Ltd offers high-purity diosmin (≥90%) for B2B buyers in the dietary supplement, pharmaceutical, and cosmetic industries.


2. Natural Sources: Citrus Bioflavonoids and the Diosmin-Hesperidin Relationship

2.1 Primary Botanical Sources

Diosmin occurs naturally in citrus fruits, primarily in the peel and pulp:

SourceDiosmin ContentCommercial Viability
Citrus sinensis (Sweet Orange) peelModerate★★★★★ (Primary commercial source)
Citrus aurantium (Bitter Orange)High★★★★☆
Citrus limon (Lemon)Moderate★★★☆☆
Citrus paradisi (Grapefruit)Low-Moderate★★☆☆☆

2.2 The Diosmin-Hesperidin Relationship

Diosmin and hesperidin are closely related flavonoid glycosides that share a common biosynthetic pathway:

  • Hesperidin (hesperetin-7-rutinoside): The most abundant citrus flavonoid; precursor to diosmetin

  • Diosmetin (4′-methoxy-luteolin): The aglycone of diosmin; more bioactive than hesperetin

  • Diosmin (diosmetin-7-rutinoside): Formed by methylation of hesperidin; more potent venotonic activity

The metabolic relationship can be simplified as:Hesperidin → Hesperetin → (methylation) → Diosmetin → (glycosylation) → Diosmin

2.3 The Synergistic Combination

The most clinically validated formulation of diosmin is MPFF (Micronized Purified Flavonoid Fraction), which combines:

ComponentProportionRole
Diosmin90%Primary venotonic and vasoprotective agent
Hesperidin (as hesperidin expressed as diosmin)10%Enhances diosmin absorption and adds complementary vasoprotective activity

This 90:10 ratio has been validated in over 60 clinical trials and is the basis for most pharmaceutical-grade diosmin products.


3. Clinical Evidence for Chronic Venous Insufficiency and Varicose Veins

3.1 Chronic Venous Insufficiency (CVI)

Chronic venous insufficiency affects 20–40% of adults in developed countries, manifesting as leg heaviness, swelling, pain, cramps, and visible varicose veins.

Meta-Analysis (18 RCTs, n = 2,329)

  • Leg heaviness: Significant improvement (OR = 3.29 vs. placebo)

  • Leg pain: Significant reduction (OR = 2.67)

  • Nocturnal cramps: Significant improvement (OR = 2.85)

  • Ankle circumference (edema): Significant reduction

  • Overall global efficacy: 70–80% of patients showed improvement

3.2 Varicose Veins

  • Study (n = 180): MPFF (1,000 mg/day) for 6 months significantly reduced varicose vein symptoms, including leg heaviness, pain, and edema

  • Mechanism: Venotonic effect (increased venous tone), improved lymphatic drainage, and reduced capillary permeability

3.3 Mechanisms of Venotonic Action

  1. Increased venous tone: Diosmin increases the responsiveness of venous smooth muscle to norepinephrine, enhancing venous return

  2. Reduced capillary permeability: Strengthens capillary walls and reduces fluid extravasation

  3. Improved lymphatic function: Increases lymphatic vessel contraction frequency and amplitude, enhancing lymph drainage

  4. Anti-inflammatory: Reduces leukocyte adhesion and activation in venous endothelium, preventing inflammatory damage


4. Hemorrhoid Treatment: Acute Episodes and Maintenance Therapy

4.1 Acute Hemorrhoidal Attacks

Diosmin (as MPFF) is the most extensively studied natural treatment for acute hemorrhoidal episodes:

Study (n = 120, acute hemorrhoidal attack)

  • Intervention: MPFF 3,000 mg/day for 4 days, then 2,000 mg/day for 3 days

  • Results: 94.4% of patients showed significant improvement within 3 days

  • Bleeding, pain, and discharge were significantly reduced compared to placebo

4.2 Maintenance Therapy

  • Study (n = 300): MPFF 500 mg twice daily for 3 months significantly reduced the frequency and severity of hemorrhoidal recurrences

  • Prevention of recurrence: 39% reduction in recurrence rate compared to placebo

4.3 Clinical Guidelines

Diosmin-based therapy (MPFF) is included in:

  • American Society of Colon and Rectal Surgeons (ASCRS) guidelines for hemorrhoid management

  • European Society of Coloproctology clinical practice guidelines

  • World Society of Emergency Surgery (WSES) guidelines for acute hemorrhoidal disease


5. Mechanisms of Action: Venotonic, Vasoprotective, and Anti-Inflammatory

5.1 Venotonic Effects

  • Norepinephrine sensitization: Diosmin increases the sensitivity of α-adrenergic receptors in venous smooth muscle, enhancing venous tone without increasing circulating catecholamines

  • Venous capacitance reduction: Decreases venous volume and pooling, improving venous return to the heart

5.2 Vasoprotective Effects

  • Capillary resistance: Strengthens capillary walls by reducing hyaluronidase activity (which degrades the capillary basement membrane)

  • Capillary permeability: Reduces fluid and protein leakage from capillaries, decreasing edema

  • Microcirculation: Improves blood flow velocity in the microcirculation, reducing stasis

5.3 Anti-Inflammatory Effects

Diosmin's anti-inflammatory action in venous disease involves multiple pathways:

  1. Leukocyte-endothelium interaction: Inhibits expression of adhesion molecules (ICAM-1, VCAM-1, E-selectin) on venous endothelial cells

  2. Leukocyte activation: Reduces production of inflammatory mediators (thromboxane B2, prostaglandin E2, free radicals) by activated leukocytes

  3. Lymphatic activation: Stimulates lymphatic vessel contraction, reducing interstitial fluid accumulation and inflammatory mediator concentration

  4. Cytokine modulation: Reduces production of TNF-α, IL-1β, and IL-6 in venous tissue

5.4 Antioxidant Activity

  • Free radical scavenging: Diosmin and its metabolites scavenge superoxide anions, hydroxyl radicals, and peroxynitrite

  • Enzymatic antioxidant support: Enhances endogenous antioxidant enzyme activity (SOD, catalase)

  • Lipid peroxidation inhibition: Protects cell membrane lipids from oxidative damage


6. Lymphatic Health and Edema Management

6.1 Lymphatic Function Enhancement

Diosmin is one of the few natural compounds with demonstrated effects on lymphatic function:

  • Increased lymphatic contraction frequency: Animal studies show 30–50% increase in lymphatic vessel contraction rate

  • Increased lymphatic contraction amplitude: Enhanced pumping efficiency improves lymph drainage

  • Reduced lymphatic capillary permeability: Decreases protein and fluid leakage into interstitial spaces

6.2 Edema Management

Study (n = 60, post-surgical edema)

  • Intervention: MPFF (1,000 mg/day) for 30 days post-surgery

  • Results: Significant reduction in limb circumference and improved mobility compared to control group

Lymphedema (Breast Cancer-Related)

  • Study (n = 40): MPFF supplementation significantly reduced arm volume and improved quality of life in women with breast cancer-related lymphedema

  • Mechanism: Enhanced lymphatic drainage and reduced interstitial fluid accumulation


7. Quality Standards, Particle Size, and Micronized Diosmin

7.1 Micronization: Why Particle Size Matters

The particle size of diosmin significantly affects its absorption and clinical efficacy:

Particle SizeRelative BioavailabilityClinical Efficacy
Non-micronized (>10 μm)Baseline (1x)Standard
Micronized (2–5 μm)1.5–2xEnhanced
Ultra-micronized (<2 μm)2–3xOptimal

MPFF (Daflon 500) uses a micronization process that reduces particle size to approximately 2 μm, significantly enhancing absorption compared to non-micronized diosmin.

7.2 Key Quality Specifications

ParameterStandard
Diosmin content (HPLC)≥ 90% (pharmaceutical grade); ≥ 80% (supplement grade)
Hesperidin content≤ 5%
Particle size (D90)≤ 5 μm (micronized); ≤ 10 μm (standard)
Loss on drying≤ 5.0%
Heavy metals≤ 10 ppm
Pesticide residuesEU/US compliant
Residual solventsComplies with ICH guidelines

7.3 Analytical Methods

  • HPLC: Primary method for diosmin quantification (UV detection at 280 nm)

  • Laser diffraction: Particle size distribution analysis

  • Dissolution testing: In vitro dissolution rate assessment

  • Microscopy: Visual confirmation of particle morphology


8. How to Source Premium Diosmin: A Buyer's Guide

8.1 Evaluating Suppliers

  1. What is the diosmin content? — ≥90% for pharmaceutical applications; ≥80% for supplements

  2. Is the product micronized? — Particle size significantly affects bioavailability

  3. What is the hesperidin content? — Should be low (<5%) for pure diosmin; ~10% for MPFF-type products

  4. What is the extraction method? — Alkaline hydrolysis of citrus hesperidin followed by methylation is the standard industrial process

  5. Is third-party testing available? — Request HPLC chromatograms and particle size distribution data

8.2 Common Quality Issues

  • Low diosmin content: Adulteration with cheaper citrus bioflavonoid extracts

  • Incorrect particle size: Non-micronized material sold as micronized

  • High hesperidin content: Inadequate conversion from hesperidin

  • Residual solvents: Improper removal of processing solvents

  • Inconsistent batch quality: Variability in content and particle size between batches

8.3 Regulatory Requirements by Application

ApplicationRegulatory FrameworkKey Requirements
PharmaceuticalGMP, pharmacopoeial standards≥90% purity, micronized, full validation
Dietary supplementFDA/EFSA supplement regulations≥80% purity, COA, safety data
CosmeticCosmetic ingredient regulations≥80% purity, heavy metals testing


9. Applications in Supplements, Pharmaceuticals, and Topical Formulations

9.1 Dietary Supplements

  • Venous health capsules: 500–1,000 mg diosmin per serving

  • Hemorrhoid support: Often combined with horse chestnut, butcher's broom, and pine bark extract

  • Circulatory health formulas: Blended with vitamin C, grape seed extract, and gotu kola

  • Combination with hesperidin: 90:10 ratio (MPFF-type) for maximum clinical efficacy

9.2 Pharmaceutical Products

  • MPFF (Daflon 500): Prescription medication for CVI and hemorrhoidal disease

  • Generic equivalents: Various manufacturers produce MPFF-type formulations

  • Topical formulations: Diosmin-containing creams and gels for localized venous support

9.3 Cosmetics

  • Anti-cellulite formulations: Targeting microcirculation and fluid retention

  • Dark circle treatments: Addressing periorbital vascular congestion

  • Anti-aging serums: Leveraging diosmin's vasoprotective and antioxidant properties


10. Safety, Dosage, and Regulatory Compliance

10.1 Recommended Dosage

ApplicationDaily Dosage
Chronic venous insufficiency1,000 mg/day (500 mg twice daily)
Acute hemorrhoidal attack3,000 mg/day for 4 days, then 2,000 mg/day for 3 days
Hemorrhoid maintenance1,000 mg/day
Edema management1,000–1,500 mg/day
General circulatory support500–1,000 mg/day

10.2 Safety Profile

  • Well-tolerated: Mild GI disturbances (nausea, diarrhea, abdominal pain) in 2–5% of users

  • Headache and dizziness: Rare (<1%)

  • Contraindications: Known hypersensitivity to diosmin or hesperidin

  • Pregnancy: Generally considered safe (extensive use in pregnant women for hemorrhoidal treatment); consult physician

  • Drug interactions: No significant drug interactions reported

10.3 Regulatory Status

RegionStatus
USADietary supplement ingredient; MPFF available as prescription
EUPrescription medication (Daflon 500); supplement ingredient
ChinaPharmaceutical ingredient (地奥司明); supplement ingredient
AustraliaListed medicine (AUST L) for venous and hemorrhoidal indications


11. Why Choose Greensky Bio as Your Diosmin Supplier

Hangzhou Greensky Biological Tech Co., Ltd is a professional natural plant extract manufacturer with over 20 years of experience in botanical sourcing, extraction, and quality control.

Our Advantages

  • High-purity production: ≥90% diosmin content verified by HPLC

  • Micronization capability: Particle size control for enhanced bioavailability

  • Full quality documentation: COAs, HPLC chromatograms, particle size distribution data, TDS, SDS

  • ISO22000, BRCGS, Ecocert Organic, SGS-GMP certified facilities

  • In-house laboratory with GC, HPLC, UV analytical capabilities

  • Flexible product formats: Standard and micronized grades to match your application needs

  • Global export experience: Serving markets in Europe, US, South Korea, and Russia

Contact Greensky Bio today for pricing, samples, and technical documentation for our Diosmin product line.


Greensky Bio — For the greensky people to provide a happy life, to make greater contribution to human health.


TAGS:
Get a Quote